Skip to main content
toggle menu
News
Press Releases
Presentations & Publications
In The News
August 2, 2022
Boston Globe
Startup IDRx raises $122m to focus on combination drug treatments
Read More
August 2, 2022
Endpoints
New biotech from Alexis Borisy will test Merck KGaA, Blueprint cancer drug combo in bid to fulfill Gleevec promise
Read More
August 2, 2022
Biopharma Dive
IDRx, a new biotech startup, raises $122M to develop better cancer drug combinations
Read More
August 2, 2022
StatNews
Alexis Borisy, biotech’s ‘man of many hats,’ dons another
Read More